Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Clinical trial NCT02620800 · COMPLETED

Trial details

NCT number: NCT02620800
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreas Adenocarcinoma

Start date: 2016-01-18
Primary completion: 2018-10-29
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.